| Literature DB >> 18470312 |
Jill A Engel-Cox1, Bennett Van Houten, Jerry Phelps, Shyanika W Rose.
Abstract
OBJECTIVE: Federal, state, and private research agencies and organizations have faced increasing administrative and public demand for performance measurement. Historically, performance measurement predominantly consisted of near-term outputs measured through bibliometrics. The recent focus is on accountability for investment based on long-term outcomes. Developing measurable outcome-based metrics for research programs has been particularly challenging, because of difficulty linking research results to spatially and temporally distant outcomes. Our objective in this review is to build a logic model and associated metrics through which to measure the contribution of environmental health research programs to improvements in human health, the environment, and the economy. DATA SOURCES: We used expert input and literature research on research impact assessment. DATA EXTRACTION: With these sources, we developed a logic model that defines the components and linkages between extramural environmental health research grant programs and the outputs and outcomes related to health and social welfare, environmental quality and sustainability, economics, and quality of life. DATA SYNTHESIS: The logic model focuses on the environmental health research portfolio of the National Institute of Environmental Health Sciences (NIEHS) Division of Extramural Research and Training. The model delineates pathways for contributions by five types of institutional partners in the research process: NIEHS, other government (federal, state, and local) agencies, grantee institutions, business and industry, and community partners.Entities:
Keywords: conceptual model development; environmental health research; metrics development; performance measurement; research impact evaluation
Mesh:
Year: 2008 PMID: 18470312 PMCID: PMC2367676 DOI: 10.1289/ehp.10925
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Figure 1Logic model of the NIEHS extramural research program. Arrows represent linkages between the logic model components. Pathways are identified by letter and color as follows: (A) NIEHS and (other) government pathway (purple) illustrates the research process from inputs to outcomes created by, provided by, or carried out by NIEHS as an agency or by NIEHS staff. It also includes the outcomes related to other federal, state, or local government agencies—specifically, policy assessments, monitoring or surveillance systems, and new laws, regulations, and standards—leading to improvements in the environment and resulting in reduced human exposure. (B) The grantee institution pathway (light blue) illustrates the research process controlled by grant-funded institutions and conducted by grant-supported investigators. It describes various uses for grant funds for research and development of staff and communities of science, leading to guidelines and scientific knowledge that result in clinical practice changes by health care providers to improved human health. (C) The business and industry pathway (orange) illustrates the commercial contribution to the research process provided most frequently by businesses and their representatives, including public–private cooperative research to develop new patents, drugs, products, and services. This institutional path also reflects business and industry’s environmental health impacts; these include their actions and responses to regulations that lead to changes in operations that reduce environmental hazards and reduce emissions. (D) The community pathway (dark blue) describes the participation of partners in the research process, such as nongovernmental organizations, community hospitals and clinics, schools, and the general public. The model includes the facilitation of (and participation in) research by the community as well as education and training, community outreach, and public awareness about the research, that in turn results in behavior changes, community advocacy, and personal and local choices that reduce negative impact on human health.
Figure 2Contribution of NIEHS and other government agencies to the logic model.
Figure 5Contribution of community and public partners to the logic model.
Example metrics for logic model components.
| ID | Pathway component | Example metrics | |
|---|---|---|---|
| NIEHS and other government pathway | |||
| A | NIEHS grant programs | Amount of funding by year, by type | |
| A1 | Grant awarding | Number of research grants awarded by year, by type | |
| A2 | Program formulation | Amount of funding for new initiatives or programs, by year, by type | |
| A3 | Information transfer | Number of staff or grantee testimonies and briefings to decision makers, by year | |
| A4 | Agency-funded research result dissemination | Number of press releases (research results, program announcements), by year, by type; number of conferences sponsored by agency, by year | |
| A5 | Awareness of research | Number of professional conferences, workshops, and research events attended by NIEHS staff | |
| A6 | Policy assessments | Number of policy documents issued that cite NIEHS-funded research, by year | |
| A7 | Monitoring and surveillance | Number of monitoring/surveillance measures instituted citing NIEHS-funded research, by year | |
| A8 | Identification of scientific needs/new science | Number of new research opportunities identified in NIEHS strategy and planning documents | |
| A9 | Laws, regulations, standards | Number of regulations/standards that cite NIEHS-funded research in support documents, by year | |
| A10 | New grant programs | Number of new initiatives or programs, by year, by type; amount of funding for new initiatives or programs, by year, by type | |
| A11 | Improved environment | Ambient air pollutant concentrations, by year; toxic chemical contamination in indoor environments by location, by year | |
| A12 | Reduced human exposure | Pollutant concentrations and measures of exposed populations | |
| Grantee institution pathway | |||
| B1 | Use of grant funds | Amount of funding by year, by source; number of investigators/fellows trained under each grant, by year | |
| B2 | Investigator career development | Number of grants awarded to investigators by year, by source | |
| B3 | Training and certifications | Number and type of certifications provided by investigators by year, by funding source | |
| B4 | Grant-funded knowledge/products | Number of presentations at selected key conferences by year, by grant type and funding source; number of peer-reviewed publications by year, by grant type and funding source | |
| B5 | Communities of science | Number of NIEHS-funded grants involving interdisciplinary/cross-collegiate principal investigators; number of Memoranda of Understanding between grantee institutions | |
| B6 | Replication and new research | Number of citations of previously published research funded by NIEHS, by year (multiple years); impact factor of each citation as measured by ISI | |
| B7 | Guidelines/recommendations | Number of clinical guidelines published that cite NIEHS-funded research, by year | |
| B8 | Accumulation of knowledge | Number of citations in the literature of previously published research funded by NIEHS, by year | |
| B9 | Clinical practice changes | Type of self-reported changes in clinical practice reported by health care providers, by year | |
| Business and industry pathway | |||
| C1 | Product development and cooperative research | Amount of industry funding matching NIEHS grant funding, by year; amount of Cooperative Research and Development Agreement (CRADA) funding by year, by type | |
| C2 | Use of NIEHS research | Number of industry trade publications that reference NIEHS research | |
| C3 | Patents and new drug applications | Number of patents that cite NIEHS-funded research, by year; number of new drugs or products that cite NIEHS-funded research in the patent | |
| C4 | Commercial products and drugs | Amount (dollars) from sale of products that cite NIEHS-funded research in the patent or were developed under a NIEHS CRADA, by year | |
| C5 | Awareness of environmental health impacts and regulations | Number and source of voluntary programs undertaken by companies that cite NIEHS-funded research as supporting evidence, by year | |
| C6 | Operations change to reduce hazards | Number of products or drugs withdrawn from the market, by year; number of businesses that change operations to eliminate hazardous materials, by year | |
| C7 | Reduced emissions | Air pollutant emissions inventory, by year; releases of toxics to all media, by year | |
| Community pathway | |||
| D1 | Research facilitation | Number of research projects participated in or facilitated in a community, by year | |
| D2 | Education and training | Number of persons who receive formal training in a community, by year | |
| D3 | Community outreach | Number of outreach events in a community, by year, by type | |
| D4 | Public awareness | Number of public awareness campaigns citing NIEHS-funded research, by year | |
| D5 | Knowledge/attitude change | Surveys of public’s knowledge and attitude changes regarding key NIEHS issues, by year | |
| D6 | Behavior change/advocacy | Surveys of public’s behavior change with regard to key NIEHS issues or topics, by year | |
| E | Ultimate outcomes | Trends in health care use/costs associated with exposures to adverse EH agents, by year; disease-specific mortality rate, by year | |
ID, identifier.
Figure 3Contribution of grantee institutions to the logic model.
Figure 4Contribution of business and industry to the logic model.
Figure 6Influence of NIEHS research on cardiovascular disease, fine PM effects, and policy changes. This figure traces how NIEHS-supported research on the role of fine PM in the etiology of cardiovascular disease has led to changes in air quality standards.
Figure 7Influence of NIEHS research on a reduction of blood lead levels through policy changes. This figure links NIEHS-supported research to policy changes leading to removal of lead from gasoline and subsequent decreases in human blood lead levels.